Delivery Order SPE2DB24D2106-SPE2DB24FAUKN
Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.30 firm fixed-price contract is for the delivery of MOVIPREP POWDER PACKETS, with a completion date of June 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,001.76 and has an ultimate completion date of May 10, 2024. The contract is for the delivery of MOVIPREP powder packets, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,230.97, is for the supply of MOVIPREP powder packets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,505.84 contract is to provide MOVIPREP powder packets, a medication used for bowel preparation procedures. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,201.57, is for the supply of MOVIPREP POWDER PACKETS, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,311.35 and has an ultimate completion date of April 19, 2024. The contract is part of the DLA's Medical Supply Chain program and is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, DMS...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $76,011.60 firm fixed-price contract is for the prime vendor supply of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $1,030.00 firm fixed-price delivery order placed by the Defense Logistics Agency's (DLA) Medical Supply Chain division. The award provides a variety of pharmaceutical products, including both branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to military and government healthcare facilities. The contract has an award value of $37,053.68 and a completion date of April 10, 2024. The contract is a delivery order under a larger indefinite delivery vehicle (IDV) contract, contract #SPE2DB, which has a ceiling value of up to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price Delivery Order valued at $2,798.95 with a period of performance through February 28, 2024. The award was made by the Defense Logistics Agency (DLA) and encompasses the supply of various pharmaceutical products, including medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This Delivery...